Dopamine reuptake inhibitor
Dopamine Reuptake Inhibitor
Dopamine reuptake inhibitors (== Template:IPA ==
The Template:IPA (International Phonetic Alphabet) is a system of phonetic notation based primarily on the Latin alphabet. It was devised by the International Phonetic Association in the late 19th century as a standardized representation of the sounds of spoken language.
Pronunciation
The pronunciation of the term "IPA" is /aɪ piː eɪ/ in English.
Etymology
The term "IPA" is an acronym for the International Phonetic Alphabet. The International Phonetic Association, founded in 1886, created the IPA to provide a single, universal system for the transcription of spoken language.
Related Terms
- Phonetic notation: A system used to visually represent the sounds of speech. The IPA is one type of phonetic notation.
- Phonetics: The study of the physical sounds of human speech. It is concerned with the physical properties of speech sounds (phonemes), and the processes of their physiological production, auditory reception, and neurophysiological perception.
- Phonology: The study of the way sounds function within a particular language or languages. While phonetics concerns the physical production, acoustic transmission and perception of the sounds of speech, phonology describes the way sounds function within a particular language or languages.
- Transcription (linguistics): The systematic representation of spoken language in written form. The source of the words transcribe and transcription, the term means "to write across" in Latin, and it's the process of converting spoken language into written form. In linguistics, this is often done using the IPA.
External links
- Medical encyclopedia article on Dopamine reuptake inhibitor
- Wikipedia's article - Dopamine reuptake inhibitor
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski), often abbreviated as DRI, are a type of drug that acts as a reuptake inhibitor for the neurotransmitter dopamine by blocking the action of the dopamine transporter (DAT). This increases the extracellular concentrations of dopamine and enhances dopaminergic neurotransmission.
Etymology
The term "Dopamine" is derived from its chemical name: 3,4-dihydroxyphenethylamine, and "reuptake inhibitor" refers to its function of blocking the reuptake of neurotransmitters into the pre-synaptic neuron, increasing the amount of dopamine available in the synaptic cleft.
Mechanism of Action
Dopamine reuptake inhibitors work by binding to the dopamine transporter and blocking the removal of dopamine from the synaptic cleft. This results in an increase in the concentration of dopamine in the synaptic cleft, which can lead to increased dopaminergic neurotransmission.
Related Terms
- Dopamine: A neurotransmitter that plays several important roles in the brain and body.
- Reuptake inhibitor: A type of drug that inhibits the reuptake of a neurotransmitter from the synapse into the presynaptic neuron, leading to an increase in the extracellular concentrations of the neurotransmitter.
- Dopamine transporter: A membrane-spanning protein that pumps the neurotransmitter dopamine out of the synaptic cleft back into cytosol.
- Neurotransmitter: Endogenous chemicals that enable neurotransmission.
See Also
- Selective serotonin reuptake inhibitor (SSRI)
- Norepinephrine reuptake inhibitor (NRI)
- Serotonin–norepinephrine reuptake inhibitor (SNRI)
External links
- Medical encyclopedia article on Dopamine reuptake inhibitor
- Wikipedia's article - Dopamine reuptake inhibitor
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski